Results 221 to 230 of about 1,925,354 (375)
The Cost-Effectiveness of Initiating Patients on Home Dialysis Compared with In-Centre Haemodialysis. [PDF]
Hill H +9 more
europepmc +1 more source
In individuals with type 1 diabetes, immune cell infiltration in the colon mucosa tended to correlate with fecal and systemic markers of intestinal permeability and inflammation, as well as gastrointestinal symptoms. These findings suggest that low‐grade gut immune activation might link the intestinal barrier dysfunction with systemic endotoxin ...
Polina Zalizko +13 more
wiley +1 more source
ABSTRACT Background While the immediate effect of exposure to severe weather from hurricanes on mortality is well documented, it is unknown whether mortality in the year following exposure to severe weather differs across older Americans with specific vulnerable characteristics. This paper sought to determine whether the association between exposure to
Sue Anne Bell +8 more
wiley +1 more source
Reflections on Gerontological Nursing Over the Past 50 Years
Journal of Advanced Nursing, EarlyView.
Wendy Moyle
wiley +1 more source
Brain structure as a mediator of the relationship of impaired kidney function and physical function. ABSTRACT Background Older adults with chronic kidney disease (CKD) experience deficits in physical function and cardiorespiratory fitness at higher rates than older adults without impaired renal function.
Julie S. Rekant +7 more
wiley +1 more source
Addressing the inequity of access to home Dialysis in Europe: recommendations for action informed by an international consensus exercise. [PDF]
Davies SJ +15 more
europepmc +1 more source
Perceptions of Multidisciplinary Renal Team Members toward Home Dialysis Therapies
Krishna Poinen +4 more
openalex +1 more source
The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui +11 more
wiley +1 more source
International equity in access to home dialysis. [PDF]
Iyengar A +3 more
europepmc +1 more source

